Stable Isotope Labelled Istiratumab Biosimilar – Anti-ERBB3/IGF1R/CD221 mAb – Research Grade

Reference: PX-TA1381-SIL-1MG
Product nameStable Isotope Labelled Istiratumab Biosimilar - Anti-ERBB3/IGF1R/CD221 mAb - Research Grade
SourceCAS 1509928-04-4
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsMM-005,MM-141
ReferencePX-TA1381-SIL
Related ProductsPX-P4554
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa -[scFv]2
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-ERBB3/IGF1R/CD221[Homo sapiens] (Istiratumab) Monoclonal Antibody

Istiratumab is investigated for the treatment of Front-line Metastatic Pancreatic Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Istiratumab Biosimilar – Anti-ERBB3/IGF1R/CD221 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products